about
sameAs
Evaluation of the pharmacokinetics, safety and clinical efficacy of ziprasidone for the treatment of schizophrenia and bipolar disorder.Novel Atypical Antipsychotics: Metabolism and Therapeutic Drug Monitoring (TDM).Current advances in biosampling for therapeutic drug monitoring of psychiatric CNS drugs.Dialyzability of Oxycodone and Its Metabolites in Chronic Noncancer Pain Patients with End-Stage Renal Disease.Biosampling strategies for emerging drugs of abuse: towards the future of toxicological and forensic analysis.LC-MS/MS and volumetric absorptive microsampling for quantitative bioanalysis of cathinone analogues in dried urine, plasma and oral fluid samples.Bioactive molecules as authenticity markers of Italian Chinotto (Citrus×myrtifolia) fruits and beverages.A fast and feasible microextraction by packed sorbent (MEPS) procedure for HPLC analysis of the atypical antipsychotic ziprasidone in human plasma.Monitoring of chronic Cannabis abuse: an LC-MS/MS method for hair analysis.Analytical Profiling of Bioactive Phenolic Compounds in Argan (Argania spinosa) Leaves by Combined Microextraction by Packed Sorbent (MEPS) and LC-DAD-MS/MS.Quantitative evaluation of auraptene and umbelliferone, chemopreventive coumarins in citrus fruits, by HPLC-UV-FL-MS.Enantioseparation and determination of asenapine in biological fluid micromatrices by HPLC with diode array detection.Increased oxytocin levels among abstinent heroin addicts: Association with aggressiveness, psychiatric symptoms and perceived childhood neglect.New-Generation, non-SSRI Antidepressants: Therapeutic Drug Monitoring and Pharmacological Interactions. Part 1: SNRIs, SMSs, SARIsDetermination of oxycodone and its major metabolites in haematic and urinary matrices: Comparison of traditional and miniaturised sampling approaches.Dried haematic microsamples and LC-MS/MS for the analysis of natural and synthetic cannabinoids.Novel mixed vesicles containing lactobacilli biosurfactant for vaginal delivery of an anti-Candida agent.Δ⁹-Tetrahydrocannabinol-induced anti-inflammatory responses in adolescent mice switch to proinflammatory in adulthood.Effects of oral d-aspartate on sperm quality in B6N miceAnalytical profiling of selected antioxidants and total antioxidant capacity of goji (Lycium spp.) berriesDried blood spot testing: a novel approach for the therapeutic drug monitoring of ziprasidone-treated patientsBlood and Plasma Volumetric Absorptive Microsampling (VAMS) Coupled to LC-MS/MS for the Forensic Assessment of Cocaine ConsumptionFeedback from the Fifth European Bioanalysis Forum Young Scientist SymposiumPerspectives and strategies for anti-doping analysisEncapsulations of wild garlic (Allium ursinum L.) extract using spray congealing technologyAnalysis of Artemisia annua extracts and related products by high performance liquid chromatography-tandem mass spectrometry coupled to sample treatment miniaturisationBotanical Sources, Chemistry, Analysis, and Biological Activity of Furanocoumarins of Pharmaceutical InterestAn Original HPLC Method with Coulometric Detection to Monitor Hydroxyl Radical Generation via Fenton ChemistryCannabinoids from Cannabis sativa L.: A New Tool Based on HPLC-DAD-MS/MS for a Rational Use in Medicinal ChemistryTutorial: Volumetric absorptive microsampling (VAMS)Thymus vulgaris L. Essential Oil Solid Formulation: Chemical Profile and Spasmolytic and Antimicrobial EffectsMicrosampling and LC-MS/MS for antidoping testing of glucocorticoids in urine
P50
Q38284625-FF020582-D676-40EB-ABC9-EAE1947C638DQ38511970-19D09F3C-F18A-4AFC-9FB3-F17A24CFAD19Q38571074-2059B8AE-E0CE-48D3-9856-AADD526E29CFQ38824938-F1679DEA-11AA-428E-8DB4-B93E9751CC90Q38841067-15C5DCFA-1AF9-4E2B-94DD-BD7EDB59431EQ38904584-49C5A24E-09C8-4CAD-9DD4-AD6A13D111E5Q41719765-EEC52975-1D6F-43FA-9998-AAAF72DED635Q43968210-44300372-854B-41F7-B1BC-7AB106F3F4E1Q46015405-76B00955-8AF7-489C-BD02-9337CAED6FEFQ46560901-18040F09-E23D-4184-8F0C-0EC46850D276Q46920750-2BC0D647-52F1-4B99-89A1-B2F16FE3A56BQ47268799-6D2455BF-6A58-4FE3-B3BA-724336DEF1CDQ47353106-76D4750F-4457-468B-8177-A020EA9B6FE8Q47827255-17888838-C61D-4573-8481-1C25688C74FCQ48503553-D81D5A06-0A8B-4667-B0CF-EEF27BE68BA8Q48711147-9585FD83-CE3F-4A17-98E1-C601EE766CF9Q50017102-DEA8993B-DCE3-47BB-B3DE-76DB861D1573Q52304505-1D6589F0-F645-473D-9912-8C3ADED54009Q56348655-B1292D52-578A-48D4-A0A5-D605CD5BAD86Q56958241-C3AE4A28-C246-4BC8-B8EB-AB84BA53584AQ56974058-19843E8D-72A3-46CB-BD67-7685436281BCQ89944067-22F6F6D4-805C-42E9-96F6-C5B340ACECEFQ90072372-D60FFE5D-5461-4B91-8BD8-A612F8A06389Q91135864-39DBCE62-B2A0-4C35-B79F-575FFBEF2B0DQ92450788-30F6D239-7358-4510-99E8-CAE409E617EEQ92490356-97B6F7F9-8402-44D0-A34F-8F0F6815F32FQ92636419-BA730083-2163-45FD-90CE-204767DE9195Q92875548-6120AE29-7F02-46B8-B696-DD083A44CD6BQ93166716-40F486D9-8B67-47B9-8B4F-713BC1BA7A6CQ93346319-2180F15C-08A1-46A9-998C-6E2C7E21B99DQ96227318-D8118B1E-2A03-491F-9E12-CF85B6700709Q96339590-6E2CA9A9-E620-4341-A612-59E8BA728F1A
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Michele Protti
@ast
Michele Protti
@en
Michele Protti
@es
Michele Protti
@nl
type
label
Michele Protti
@ast
Michele Protti
@en
Michele Protti
@es
Michele Protti
@nl
prefLabel
Michele Protti
@ast
Michele Protti
@en
Michele Protti
@es
Michele Protti
@nl
P106
P1153
55553462400
P31
P496
0000-0001-9310-4957